Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma

Michael R. Green, Carlos Aya-Bonilla, Maher K. Gandhi, Rod A. Lea, Jeremy Wellwood, Peter Wood, Paula Marlton, Lyn R. Griffiths

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Recent developments in genomic technologies have resulted in increased understanding of pathogenic mechanisms and emphasized the importance of central survival pathways. Here, we use a novel bioinformatic based integrative genomic profiling approach to elucidate conserved mechanisms of lymphomagenesis in the three commonest non-Hodgkin's lymphoma (NHL) entities: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia. By integrating genome-wide DNA copy number analysis and transcriptome profiling of tumor cohorts, we identified genetic lesions present in each entity and highlighted their likely target genes. This revealed a significant enrichment of components of both the apoptosis pathway and the mitogen activated protein kinase pathway, including amplification of the MAP3K12 locus in all three entities, within the set of genes targeted by genetic alterations in these diseases. Furthermore, amplification of 12p13.33 was identified in all three entities and found to target the FOXM1 oncogene. Amplification of FOXM1 was subsequently found to be associated with an increased MYC oncogenic signaling signature, and siRNA-mediated knock-down of FOXM1 resulted in decreased MYC expression and induced G2 arrest. Together, these findings underscore genetic alteration of the MAPK and apoptosis pathways, and genetic amplification of FOXM1 as conserved mechanisms of lymphomagenesis in common NHL entities. Integrative genomic profiling identifies common central survival mechanisms and highlights them as attractive targets for directed therapy.

Original languageEnglish (US)
Pages (from-to)313-326
Number of pages14
JournalGenes Chromosomes and Cancer
Volume50
Issue number5
DOIs
StatePublished - May 1 2011

Fingerprint

Non-Hodgkin's Lymphoma
Carcinogenesis
Apoptosis
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Gene Expression Profiling
B-Cell Chronic Lymphocytic Leukemia
Mitogen-Activated Protein Kinases
Computational Biology
Oncogenes
Small Interfering RNA
Genes
Genome
Technology
DNA
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Green, M. R., Aya-Bonilla, C., Gandhi, M. K., Lea, R. A., Wellwood, J., Wood, P., ... Griffiths, L. R. (2011). Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes and Cancer, 50(5), 313-326. https://doi.org/10.1002/gcc.20856

Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. / Green, Michael R.; Aya-Bonilla, Carlos; Gandhi, Maher K.; Lea, Rod A.; Wellwood, Jeremy; Wood, Peter; Marlton, Paula; Griffiths, Lyn R.

In: Genes Chromosomes and Cancer, Vol. 50, No. 5, 01.05.2011, p. 313-326.

Research output: Contribution to journalArticle

Green, MR, Aya-Bonilla, C, Gandhi, MK, Lea, RA, Wellwood, J, Wood, P, Marlton, P & Griffiths, LR 2011, 'Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma', Genes Chromosomes and Cancer, vol. 50, no. 5, pp. 313-326. https://doi.org/10.1002/gcc.20856
Green, Michael R. ; Aya-Bonilla, Carlos ; Gandhi, Maher K. ; Lea, Rod A. ; Wellwood, Jeremy ; Wood, Peter ; Marlton, Paula ; Griffiths, Lyn R. / Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. In: Genes Chromosomes and Cancer. 2011 ; Vol. 50, No. 5. pp. 313-326.
@article{9935a24edd7247c49de3ccc97658237a,
title = "Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma",
abstract = "Recent developments in genomic technologies have resulted in increased understanding of pathogenic mechanisms and emphasized the importance of central survival pathways. Here, we use a novel bioinformatic based integrative genomic profiling approach to elucidate conserved mechanisms of lymphomagenesis in the three commonest non-Hodgkin's lymphoma (NHL) entities: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia. By integrating genome-wide DNA copy number analysis and transcriptome profiling of tumor cohorts, we identified genetic lesions present in each entity and highlighted their likely target genes. This revealed a significant enrichment of components of both the apoptosis pathway and the mitogen activated protein kinase pathway, including amplification of the MAP3K12 locus in all three entities, within the set of genes targeted by genetic alterations in these diseases. Furthermore, amplification of 12p13.33 was identified in all three entities and found to target the FOXM1 oncogene. Amplification of FOXM1 was subsequently found to be associated with an increased MYC oncogenic signaling signature, and siRNA-mediated knock-down of FOXM1 resulted in decreased MYC expression and induced G2 arrest. Together, these findings underscore genetic alteration of the MAPK and apoptosis pathways, and genetic amplification of FOXM1 as conserved mechanisms of lymphomagenesis in common NHL entities. Integrative genomic profiling identifies common central survival mechanisms and highlights them as attractive targets for directed therapy.",
author = "Green, {Michael R.} and Carlos Aya-Bonilla and Gandhi, {Maher K.} and Lea, {Rod A.} and Jeremy Wellwood and Peter Wood and Paula Marlton and Griffiths, {Lyn R.}",
year = "2011",
month = "5",
day = "1",
doi = "10.1002/gcc.20856",
language = "English (US)",
volume = "50",
pages = "313--326",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma

AU - Green, Michael R.

AU - Aya-Bonilla, Carlos

AU - Gandhi, Maher K.

AU - Lea, Rod A.

AU - Wellwood, Jeremy

AU - Wood, Peter

AU - Marlton, Paula

AU - Griffiths, Lyn R.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Recent developments in genomic technologies have resulted in increased understanding of pathogenic mechanisms and emphasized the importance of central survival pathways. Here, we use a novel bioinformatic based integrative genomic profiling approach to elucidate conserved mechanisms of lymphomagenesis in the three commonest non-Hodgkin's lymphoma (NHL) entities: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia. By integrating genome-wide DNA copy number analysis and transcriptome profiling of tumor cohorts, we identified genetic lesions present in each entity and highlighted their likely target genes. This revealed a significant enrichment of components of both the apoptosis pathway and the mitogen activated protein kinase pathway, including amplification of the MAP3K12 locus in all three entities, within the set of genes targeted by genetic alterations in these diseases. Furthermore, amplification of 12p13.33 was identified in all three entities and found to target the FOXM1 oncogene. Amplification of FOXM1 was subsequently found to be associated with an increased MYC oncogenic signaling signature, and siRNA-mediated knock-down of FOXM1 resulted in decreased MYC expression and induced G2 arrest. Together, these findings underscore genetic alteration of the MAPK and apoptosis pathways, and genetic amplification of FOXM1 as conserved mechanisms of lymphomagenesis in common NHL entities. Integrative genomic profiling identifies common central survival mechanisms and highlights them as attractive targets for directed therapy.

AB - Recent developments in genomic technologies have resulted in increased understanding of pathogenic mechanisms and emphasized the importance of central survival pathways. Here, we use a novel bioinformatic based integrative genomic profiling approach to elucidate conserved mechanisms of lymphomagenesis in the three commonest non-Hodgkin's lymphoma (NHL) entities: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia. By integrating genome-wide DNA copy number analysis and transcriptome profiling of tumor cohorts, we identified genetic lesions present in each entity and highlighted their likely target genes. This revealed a significant enrichment of components of both the apoptosis pathway and the mitogen activated protein kinase pathway, including amplification of the MAP3K12 locus in all three entities, within the set of genes targeted by genetic alterations in these diseases. Furthermore, amplification of 12p13.33 was identified in all three entities and found to target the FOXM1 oncogene. Amplification of FOXM1 was subsequently found to be associated with an increased MYC oncogenic signaling signature, and siRNA-mediated knock-down of FOXM1 resulted in decreased MYC expression and induced G2 arrest. Together, these findings underscore genetic alteration of the MAPK and apoptosis pathways, and genetic amplification of FOXM1 as conserved mechanisms of lymphomagenesis in common NHL entities. Integrative genomic profiling identifies common central survival mechanisms and highlights them as attractive targets for directed therapy.

UR - http://www.scopus.com/inward/record.url?scp=79952389490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952389490&partnerID=8YFLogxK

U2 - 10.1002/gcc.20856

DO - 10.1002/gcc.20856

M3 - Article

C2 - 21305641

AN - SCOPUS:79952389490

VL - 50

SP - 313

EP - 326

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 5

ER -